When I last wrote about the obesity treatments' specialist Eli Lilly (NYSE: LLY ) in August, there was a 50% upside to the stock following its crash after disappointing drug trial results. In the two months since, the stock has realised ~30% of the upside farManika is a macroeconomist with over 20 years of experience in industries including investment management, stock broking, investment banking. She also runs the profile Long Term Tips [LTT], which focuses on the generational opportunity in the green econ ...

The Chinese economy might still be battling stresses, but the same can't be said for its stock market. The Shanghai Composite Index ( SHCOMP ) has risen faster than the S&P 500 ( SP500Manika is a macroeconomist with over 20 years of experience in industries including investment management, stock broking, investment banking. She also runs the profile Long Term Tips [LTT], which focuses on the generational opportunity in the green economy. Her investing group, Green Growth Giants , takes the theme a step furt ...

That changes were afoot at the Danish weight management treatments' company Novo Nordisk A/S ( NVO ), (NOVO-B.CO) was already evident when its then-CEO, Lars Fruergaard Jørgensen, stepped down in May. But just howManika is a macroeconomist with over 20 years of experience in industries including investment management, stock broking, investment banking. She also runs the profile Long Term Tips [LTT], which focuses on the generational opportunity in the green economy. Her investing group, Green Growth Giants ...

Northern Graphite Announces $2.2 Million Non-Brokered Private PlacementProceeds to help finance Baie-Comeau Battery Anode Material facility feasibility study, working capitalSeptember 11, 2025 8:00 AM EDT | Source: Northern Graphite CorporationOttawa, Ontario--(Newsfile Corp. - September 11, 2025) - Northern Graphite Corporation (TSXV: NGC) (OTCQB: NGPHF) (FSE: 0NG) (XSTU: 0NG) (the "Company" or "Northern") is pleased to announce a non-brokered private placement financing (the "Private Placeme ...

Core Insights - Altria Group, Inc. (NYSE: MO) has experienced a double-digit price increase year-to-date but still lags behind its peers in the market [1] Company Analysis - Altria's performance in the stock market has been under scrutiny, particularly in comparison to its competitors, despite a notable price increase [1] Industry Context - The article references a broader investment theme focusing on the green economy, indicating potential shifts in investment strategies within the industry [1]

Core Insights - Eli Lilly (NYSE: LLY) experienced a significant stock decline despite reporting strong Q2 2025 results and providing upgraded guidance, indicating a disconnect between company performance and investor sentiment [1]. Company Performance - The company reported robust Q2 2025 results, which typically would be expected to drive stock prices higher [1]. - The upgraded guidance suggests positive future expectations, yet the stock still plunged, highlighting potential investor concerns or market dynamics [1]. Investor Sentiment - The trading session for Eli Lilly serves as an example of investor psychology, where even strong financial results may not be enough to prevent stock price declines [1].